Pharmacovigilance Practice

Good pharmacovigilance practices (GVP) are a set of measures drawn up to grease the performance of pharmacovigilance in the European Union (EU). GVP apply to marketing authorisation holders, the European Medicines Agency (EMA) and drugs nonsupervisory authorities in EU Member States. They cover drugs authorised centrally via the Agency as well as drugs authorised at public position. Medicines aren't the only products considered under the horizon of pharmacovigilance practice, but also Vaccines, Blood products, Medical bias, and Biological, Herbals, Traditional / reciprocal substances.

    Related Conference of Pharmacovigilance Practice

    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Pharmacovigilance Practice Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in